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Abstract
In 2010, foreign-born persons accounted for 60% of all tuberculosis (TB) cases in the United States. Understanding which
national groups make up the highest proportion of TB cases will assist TB control programs in concentrating limited
resources where they can provide the greatest impact on preventing transmission of TB disease. The objective of our study
was to predict through 2020 the numbers of U.S. TB cases among U.S.-born, foreign-born and foreign-born persons from
selected countries of birth. TB case counts reported through the National Tuberculosis Surveillance System from 2000–2010
were log-transformed, and linear regression was performed to calculate predicted annual case counts and 95% prediction
intervals for 2011–2020. Data were analyzed in 2011 before 2011 case counts were known. Decreases were predicted
between 2010 observed and 2020 predicted counts for total TB cases (11,182 to 8,117 [95% prediction interval 7,262–9,073])
as well as TB cases among foreign-born persons from Mexico (1,541 to 1,420 [1,066–1,892]), the Philippines (740 to 724
[569–922]), India (578 to 553 [455–672]), Vietnam (532 to 429 [367–502]) and China (364 to 328 [249–433]). TB cases among
persons who are U.S.-born and foreign-born were predicted to decline 47% (4,393 to 2,338 [2,113–2,586]) and 6% (6,720 to
6,343 [5,382–7,476]), respectively. Assuming rates of declines observed from 2000–2010 continue until 2020, a widening gap
between the numbers of U.S.-born and foreign-born TB cases was predicted. TB case count predictions will help TB control
programs identify needs for cultural competency, such as languages and interpreters needed for translating materials or
engaging in appropriate community outreach.
Citation: Woodruff RSY, Winston CA, Miramontes R (2013) Predicting U.S. Tuberculosis Case Counts through 2020. PLoS ONE 8(6): e65276. doi:10.1371/
journal.pone.0065276
Editor: Madhukar Pai, McGill University, Canada
Received February 26, 2013; Accepted April 25, 2013; Published June 13, 2013
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ryelkwoodruff@cdc.gov
Introduction
The primary responsibility for treating, and oftentimes diag-
nosing, patients with tuberculosis (TB) and latent tuberculosis
infection (LTBI) falls to state and local TB control programs [1].
The number of current and future TB cases is an important
measure of burden on TB control programs and has implications
for setting priorities among TB prevention and control efforts.
Health departments not accustomed to serving large foreign-born
populations may experience an increase in TB cases as a result of
increasing numbers of foreign-born residents, who may be arriving
from countries with high rates of TB. As foreign-born persons
make up an increasing proportion of TB cases in the United
States, predicting TB trends will help TB control programs
identify needs for cultural competency, including foreign language
speakers and interpreters needed for translating materials or
engaging in appropriate community outreach.
Several studies have predicted future TB trends [2], [3], [4], [5],
[6], [7], [8], [9], [10] however we are not aware of any published
studies that predict future TB case counts in the United States
among foreign-born persons from specific countries of birth. As
progress continues in decreasing the burden of TB in the United
States [11], understanding TB trends among the foreign-born
groups that make up the largest proportion of TB cases will assist
TB control programs in concentrating limited resources where
they can provide the greatest impact. The purpose of this study
was to help guide TB control and program planning. We achieved
this objective by predicting the numbers of U.S. TB cases among




The National Tuberculosis Surveillance System (NTSS) collects
annual TB case information from 60 reporting areas including the
50 states and the District of Columbia [12]. NTSS data consist of
demographic, clinical, and risk factor information. Nativity (native
or U.S.-born vs. foreign-born) is determined based on a person’s
self-reported country of birth and U.S. citizenship status at birth,
and follows U.S. Census definitions [13], [14]. A reported case is
confirmed as TB according to laboratory or clinical criteria [13],
[15].
Ethics Statement
Data used in this evaluation were collected as part of routine
disease surveillance activities, and the project was not considered
to be human subjects research requiring Institutional Review
Board approval.
Trend and Prediction Analyses
Annual aggregate NTSS data from January 1, 2000, through
December 31, 2010, were analyzed to determine the proportion
and number of U.S. TB cases by nativity and to examine current
trends and predict future case counts for all TB cases, U.S.-born
TB cases, foreign-born TB cases, foreign-born TB cases from the
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top 5 countries of birth, and foreign-born TB cases from countries
of birth other than the top 5.
TB surveillance data from years 2000 through 2010 were
selected to reflect recent trends, namely the slower decline of TB
rates beginning in 2000 compared to earlier declines [16], and
because 2010 was the most recent data available in 2011, the time
of analysis. Case counts were log-transformed to better fit the
statistical assumptions of linear regression which was performed on
the log-transformed counts as the dependent variable with year as
the independent variable (regression results were back-transformed
into case counts). Regression models calculated predicted annual
case counts and 95% prediction intervals from 2011 through 2020.
In secondary analyses, we included all available data from 1993–
2010 to assess the choice of baseline year. Regression analyses
were conducted using SAS (version 9.2; SAS Institute, Cary, NC).
The regression line slope was considered significantly different
from 0 at p,0.05. The R2 coefficient of determination was
examined to assess the proportion of variability in case count that
may be explained by year.
Joinpoint Analysis
In order to assess the single linear slope assumption in our
regression analysis, trends in TB case counts were examined using
joinpoint models (Joinpoint version 3.5.2, Bethesda, MD http://
surveillance.cancer.gov/joinpoint/). Significant changes in trend,
or joinpoints, were identified by fitting a series of piece-wise
regression models to 2000–2010 TB data. The number of
allowable joinpoints ranged from 0 (a straight line, equivalent to
our linear regression model) to 3. Statistically significant changes
in trends were detected using a Monte Carlo permutation method.
Annual percent change (APC) in log counts and associated 95%
confidence intervals (CI) were calculated for each joinpoint
segment to characterize and compare trends. APC was considered
significantly different from 0 at p,0.05. Segmented linear
regression analyses to predict TB cases and 95% prediction
intervals from 2011–2020 were conducted on log-transformed case
counts for groups for which a significant joinpoint was indicated.
Segmented analysis predictions were based on the second segment
of the joinpoint analysis.
Results
From 2000 to 2010 a total of 153,353 cases of tuberculosis were
reported in the United States; 45% (69,189) were among U.S.-
born persons and 55% (83,625) were among foreign-born persons.
TB cases among U.S.-born persons declined 49% from 2000 to
2010. The number of TB cases among foreign-born persons
remained stable from 2000 to 2008 (0.6% decline), with an 11%
decline in observed counts from 2008 to 2010.
The top 5 countries of birth among foreign-born persons
diagnosed with TB for each year from 2000 to 2010 were Mexico,
the Philippines, Vietnam, India and China. The greatest numbers
of TB cases among foreign-born persons diagnosed in the United
States were consistently among persons from Mexico, followed by
the Philippines (24% and 11% of all TB cases among foreign-born
persons between 2000 and 2010, respectively).
TB Prediction Results
Regression analysis predicted a decrease between 2010
observed and 2020 predicted counts for TB cases among all
persons in the United States as well as TB cases among persons
who were U.S.-born, foreign-born, and foreign-born from Mexico,
the Philippines, India, Vietnam and China (Table 1). Among all
TB cases diagnosed in the United States, the proportion of cases
among persons who were foreign-born was predicted to increase
from 60% in 2010 to 78% by 2020. The number of TB cases
among U.S.-born persons was predicted to decline 47% from 2010
(4,393 observed cases) to 2020 (2,338 predicted cases) and the
number of TB cases among foreign-born persons was predicted to
decline 6% (6,720 observed cases to 6,343 predicted cases;
Table 1). The 95% prediction intervals for TB cases in 2020
among foreign-born persons, foreign-born persons from the top 5
countries, foreign-born persons from countries other than the top
5 and foreign-born persons from Mexico, the Philippines, India
and China included the number of cases observed in 2010. U.S.-
born persons and foreign-born persons from Vietnam were the
only groups for which the 2010 observed case count was higher
than the 2020 prediction bounds.
Model results indicated a significantly decreasing linear slope by
year during 2000–2010 for all sub-groups except foreign-born
persons from the Philippines, India, China, and foreign-born
persons born in countries other than the top 5. Of the top 5
countries of birth, TB cases among persons born in Mexico were
predicted to experience the steepest decline in numbers from 2011
to 2020 (Figure 1). The predicted decline in TB cases among
foreign-born persons was influenced by the top 5 countries of
birth; the foreign-born slope flattened and statistical significance
changed when the top 5 countries of birth were excluded (p= 0.05
compared to p= 0.01 for all foreign born; Figure 1).
Model fit was best for TB case counts from 2000 to 2010 among
U.S.-born persons (R2= 0.99), followed by TB cases among all
persons (R2 = 0.95), foreign-born persons from Vietnam
(R2= 0.81), foreign-born persons from the top 5 countries of birth
(R2 = 0.57), foreign-born persons overall (R2 = 0.51), and foreign-
born persons from Mexico (R2 = 0.41). The model had little
predictive value among foreign-born persons from countries of
birth other than the top 5 (R2= 0.35) or among foreign-born
persons from the Philippines (R2= 0.29), China (R2 = 0.29) and
India (R2 = 0.05), which had flat slopes.
Modeling 1993 through 2010 case counts resulted in predicted
increases in case counts by 2020 among foreign-born persons
overall (6,720 observed cases in 2010 to 7,123 [95% prediction
interval 6,327–8,019] predicted in 2020), foreign-born persons
from Mexico (1,541 to 1,719 [95% prediction interval 1,401–
2,108]) and foreign-born persons from India (578 to 913 [95%
prediction interval 609–1,368]), rather than the decreases
predicted when modeling case counts from 2000 through 2010.
Results for other countries were qualitatively unchanged.
Joinpoint Results
When assessing for possible significant changes in trend, a
significant joinpoint was suggested over a single slope model for
TB cases among all persons and cases among persons who were
foreign-born, foreign-born from countries of birth other than the
top 5, foreign-born from the top 5 countries of birth, and foreign-
born from Mexico (Table 2). TB cases among all foreign-born
persons exhibited similar trends as those who were foreign-born
from Mexico when modeled with no joinpoint. However, 1-
joinpoint models resulted in a significant decrease in observed
trend among all foreign-born persons occurring 3 years later than
among foreign-born persons from Mexico (Figure 2, Table 2).
Allowing the model to select a maximum of 3 joinpoints resulted in
a recommended 2-joinpoint model for Mexico with a significant
increase of 3.9% from 2000–2003, a non-significant decrease of
1.2% from 2003–2006, and a significant decrease of 5.6% from
2006–2010. All other recommended models remained the same as
shown in Table 2.
Predicting Tuberculosis Cases through 2020
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Compared to single slope results for 2000–2010, segmented
regression resulted in lower predicted TB case counts for 2020
among all persons (5,133 predicted cases [95% prediction interval
4,109–6,411]), foreign-born persons (3,976 predicted cases [3,300–
4,791]), foreign-born persons from the top 5 countries (2,147
predicted cases [1,710–2,697]), foreign-born persons from coun-
tries other than the top 5 (1,424 predicted cases [982–2,064]) and
foreign-born persons from Mexico (982 predicted cases [859–
1,122]).
Discussion
TB cases are predicted to decline among all persons in the U.S.
A steeper decline is predicted among U.S.-born than foreign-born
persons, which has implications for state and local TB control
programs and TB elimination in the U.S. Among the top 5
countries of birth of foreign-born TB patients diagnosed in the
United States, our model predicted a significant decrease and 2010
observed case count above the upper bound of the 2020 prediction
interval only for foreign-born persons from Vietnam. The
remaining countries (Mexico, the Philippines, India, and China)
exhibited flatter slopes and 2020 prediction intervals that included
the value of the 2010 observed count; consequently our model
results for 95% prediction intervals indicate that cases among
persons from these countries have the potential to increase or
decrease. Modeling case counts from a longer time period (1993 to
2010) resulted in a significant increase in predicted estimates of
cases among persons born in India, but ignores the change in the
deceleration rate of TB from the 1990s to the 2000s [16]. We
primarily presented single slope regression models for compara-
bility across groups. Using a segmented regression approach with
more than 1 slope when indicated resulted in even greater
predicted declines in TB case counts by 2020. Thus, our predicted
estimates from single slope regression models are conservative
compared to other types of prediction models.
TB cases among persons who were foreign-born and foreign-
born from the top 5 countries of birth experienced significant
changes in trend in 2007 resulting in steeper declines during the
latter part of the decade. However, among the individual top 5
countries of birth a significant change in TB case count trend from
2000–2010 was indicated only for Mexico. Mexico’s significant
changes in trends occurred in 2004 (for a single joinpoint model),
or in 2003 and 2006 (for a double joinpoint model). The single
joinpoint change in trend among foreign-born from Mexico
preceded the significant change in trend among all foreign-born by
at least 3 years. Therefore, we hypothesized that the change in
cases among persons from Mexico, which accounted for nearly a
quarter of all foreign-born TB cases in the United States,
influenced the significant change to a decreasing trend among
all foreign-born persons. When Mexico was removed from
foreign-born, results were consistent with this hypothesis; though
the slope of the regression line among foreign-born excluding
Mexico decreased in a similar manner as foreign-born including
Mexico, the change in trend among foreign-born excluding
Mexico occurred in 2008, a year later than it occurred for all
foreign-born (data not shown). Thus the decrease in TB cases
among foreign-born persons from Mexico influenced the year in
which the foreign-born change in trend occurred and, subse-
quently, will continue to influence TB trends among foreign-born
persons in coming years.
In 2001, TB case rates were 5 times higher among foreign-born
persons from Mexico than U.S.-born persons, and Mexican-born
TB patients were more likely than U.S.-born TB patients to have
multidrug-resistant TB [17]. Furthermore, in California and
Texas TB morbidity among U.S.-born persons is higher in
counties that border Mexico than in the rest of the state [17]. The
number of persons from Mexico emigrating to the U.S. declined
by 60% from 2006 to 2010 [18], however this decrease has had
minimal impact on the percentage of foreign-born TB cases
attributed to persons from Mexico [12]. The unique challenges
associated with TB among foreign-born persons from Mexico
need to be continually addressed if the decline of TB among
foreign-born persons is to be accelerated, thereby continuing the
decline of TB in the U.S. [17], [19]. Bi-national programs, such as
California’s CureTb and Texas’ TB Net, as well as TB control
programs for Mexico-born migrant workers and non-immigrants,
are necessary to diagnose, treat, and thereby reduce TB cases
among foreign-born persons from Mexico.
Immigration, which is directly affected by national policies and
socioeconomic factors [20], is an important consideration in the
number of TB cases among foreign-born persons [21], [22]. Major
changes in immigration patterns could alter our case count
predictions. In order to assess the influence of the population base
size on TB case count predictions, population denominators from
the U.S. Census Bureau’s Current Population Survey (http://
www.census.gov/cps/) were incorporated into analysis using
Table 1. 2010 observed and 2020 predicted tuberculosis (TB) case counts and 95% prediction intervals.
2010 Observed TB Case Count 2020 Predicted TB Case Count (95% Prediction Interval)
Total* 11,182 8,117 (7,262–9,073)
U.S.-born* 4,393 2,338 (2,113–2,586)
Foreign-born* 6,720 6,343 (5,382–7,476)
Foreign-born from top 5 countries* 3,755 3,446 (2,900–4,096)
Mexico* 1,541 1,420 (1,066–1,892)
Philippines 740 724 (569–922)
India 578 553 (455–672)
Vietnam* 532 429 (367–502)
China 364 328 (249–433)
Foreign-born from countries
other than top 5
2,965 2,901 (2,432–3,459)
*P,0.05 indicating the slope for 2000–2010 regression line was significantly different from zero.
doi:10.1371/journal.pone.0065276.t001
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Figure 1. Comparison of observed and predicted tuberculosis (TB) case counts among select groups, United States, 2000–2020.
Observed values for 2000–2010 reported to the National Tuberculosis Surveillance System were log transformed and logistic regression was
performed on the log transformed counts to generate predicted values for 2011–2020. Vertical bars represent 95% prediction intervals.
doi:10.1371/journal.pone.0065276.g001
Predicting Tuberculosis Cases through 2020
PLOS ONE | www.plosone.org 4 June 2013 | Volume 8 | Issue 6 | e65276
2000–2010 TB case rates. We predicted a decline in TB case rates
between 2010 observed and 2020 predicted for all persons and
persons who were U.S.-born, foreign-born, foreign-born from the
top 5 countries, foreign-born from countries other than the top 5,
and foreign-born from Mexico, the Philippines, Vietnam, India
and China (data not shown). The predicted declines in TB rates
are consistent with our TB case count prediction results.
TB prevention and control strategies, which focus on interrupt-
ing recent transmission, have been successful in reducing the
number of U.S.-born TB cases but have had limited impact on
preventing disease among foreign-born persons entering the
United States from countries with high rates of LTBI [21]. LTBI
testing and treatment of foreign-born persons from the top 5
countries of birth, particularly those persons who have recently
arrived in the U.S., would likely increase the rate of decline of TB
cases among foreign-born persons [21]. A newly recommended
LTBI treatment regimen [23], which reduces treatment time from
9 months to 12 weeks, increased LTBI treatment completion rates
among study populations [24], [25] and could increase LTBI
treatment completion in the future as the new regimen is
implemented. Unfortunately recent shortages of tuberculin skin
test antigens, used for detection of LTBI, and isoniazid, an
important drug in the treatment of LTBI and TB disease, have
restricted LTBI testing and treatment efforts in some states [26],
[27]. Continuation of these shortages could lead to underdiagnos-
es, incomplete administration of medication and treatment
completion failure resulting in an increase in new, recurrent and
drug resistant TB disease. Challenges such as these may continue
to impact the successful diagnosis and treatment of LTBI and TB
disease in the future.
In 2007, the Centers for Disease Control and Prevention issued
updated Technical Instructions (TIs) for TB screening of foreign-
born persons entering the United States [28]. The updated TIs
include guidance on performing TB culture to enhance TB
diagnosis and administering directly observed therapy to increase
treatment completion. Mexico and the Philippines began screen-
ing all applicants to the United States using the updated TIs in
2007, Vietnam in 2008, China in 2009 and India in 2010. A
preliminary study of persons immigrating to the United States
from Mexico, the Philippines and Vietnam suggests that the
updated TIs improved case detection prior to U.S. entry [29].
Evaluation of the newly implemented TIs will be important in
determining their impact on TB cases among the foreign-born.
Foreign-born persons who arrive in the United States without
going through the immigrant and refugee application process (for
example nonimmigrant visitors such as tourists and students, and
undocumented foreign-born persons) would not be evaluated
using the TIs and thus not be screened for TB regardless of their
country of birth. A recent study estimated that between 2001 and
2008 56% of TB cases among newly arrived foreign-born persons
were among nonimmigrant visitors who did not undergo TB
screening prior to arrival [30]. Furthermore, in 2008 approxi-
mately 30% of foreign-born persons in the U.S. were undocu-
mented [31]. Targeted overseas screening of nonimmigrant
visitors from countries with a high burden of TB who plan to
stay in the U.S. for a long period of time could decrease the
number of TB cases among foreign-born persons [30].
The TB prediction methodology described here did not take
into consideration factors that affect TB trends among foreign-
born persons in the United States such as TB prevalence in the
country of birth, immigration patterns, socioeconomic and health
status, and global TB control efforts, nor the potential for testing
and treatment disruptions due to shortages noted previously. In
addition, although the relationship between Human Immunode-
Table 2. Joinpointa analysis results for significant change in trend among 2000–2010 TB case counts.
0 Joinpoint Modelb 1 Joinpoint Modelb
APCc (95% CId) Yearse APC (95% CI)
Total 23.5* (24.1, 22.9) 2000–2008 22.9* (23.3, 22.6)
2008–2010 27.4* (210.2, 24.4)
US-born 26.3* (26.8, 25.7)
Foreign-born 21.2* (22.1, 20.3) 2000–2007 0.0 (20.9,1.0)
2007–2010 25.1* (28.2, 21.8)
FB from the top 5 countries 21.4* (22.3, 20.5) 2000–2007 20.2 (21.3, 1.0)
2007–2010 25.3* (29.4, 21.1)
Mexico 21.7* (23.2, 20.2) 2000–2004 3.5* (1.2, 5.8)
2004–2010 24.6* (25.7, 23.4)
Philippines 21.1 (22.4, 0.2)
India 20.3 (21.4, 0.7)
Vietnam 22.2* (23.1, 21.4)
China 21.0 (22.4, 0.5)
FB excluding top 5 countries 20.9 (21.9, 0.0) 2000–2008 20.0 (21.0, 1.0)
2008–2010 27.0* (215.2, 22.0)
aJoinpoint version 3.5.2, Bethesda, MD http://surveillance.cancer.gov/joinpoint/.
b0 joinpoint model results are included for all groups analyzed and 1 joinpoint model results are included for those which a significant change in trend was indicated.
cAPC =Annual Percent Change in TB case counts.
dCI = Confidence Interval.
eIndicates the year in which a significant change in trend occurred.
*The APC is significantly different from 0 at p,0.05. For the 1 joinpoint model, asterisks indicate which segment(s) had a significant APC. The Philippines, India and
China did not have a significant APC result from either 0 or 1 joinpoint models.
doi:10.1371/journal.pone.0065276.t002
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ficiency Virus (HIV) infection and TB is well described [32], we
were not able to incorporate information on HIV status due to
underreporting and lack of published HIV incidence and
prevalence estimates in the United States by country of origin.
We assumed current trends in TB cases will continue with cases
declining in a linear pattern; however, trends can be affected by
changes in behavior, policies, or other factors that influence
population and immigration [20], [22]. Although the linear
regression model was not a good fit for all countries, we showed
that our prediction results were generally conservative in relation
to more complex regression models.
The described prediction analysis had several strengths. The
model can be customized for different data subsets, and can be
applied to other diseases and conditions. The World Health
Organization uses a similar methodology to forecast TB preva-
lence and mortality rates [10]. Recent data show that our model
by country of origin accurately predicted 2011 TB case counts;
2011 observed case counts for all subgroups were within the 95%
prediction intervals calculated by our prediction model [12].
Results from our model closely reflect U.S.-born and foreign-born
findings from a deterministic mathematical model recently
published [4], with the additional benefit that we provide detail
by country of origin.
Conclusions
As a higher proportion of U.S. TB cases occur among foreign-
born persons, predicting foreign-born cases will assist TB control
programs in using limited resources more efficiently. Our
predictions combined with ethnographic information can be used
in the development and implementation of effective TB control
activities. For example, ethnographic research suggests some
Mexico-born populations believe TB can be transmitted through
clothing, eating utensils, and body fluids [33], thus education
about airborne transmission is a useful component of TB control
efforts in this community. CDC has developed ethnographic
guides for different foreign-born populations to aid healthcare
practitioners in developing culturally appropriate TB care and
services (http://www.cdc.gov/tb/publications/guidestoolkits/
EthnographicGuides/default.htm).
Our study is one of few that predict future numbers of TB cases
in the United States, and the only one to our knowledge that
predicts TB case counts among foreign-born persons from specific
countries of birth. Further studies that include socioeconomic and
demographic factors, TB and HIV burden in countries of birth,
and foreign-born immigration trends would enhance TB case
count predictions and provide valuable information for TB control
programs. Improving TB control among foreign-born persons is
imperative as the United States strives to prevent TB transmission
and meet elimination goals [34].
Figure 2. Number of tuberculosis (TB) cases modeled with 0 and 1 significant changes in trend for all foreign-born persons and 0, 1,
and 2 significant changes in trend for foreign-born persons fromMexico, 2000–2010. Significant changes in trend were determined using
Joinpoint analysis (Joinpoint version 3.5.2, Bethesda, MD http://surveillance.cancer.gov/joinpoint/). Arrows indicate the years in which significant
changes in trend for foreign-born persons from Mexico occurred (blue arrow corresponds to model results with a single change in trend and red
arrows correspond to model results with 2 changes in trend).
doi:10.1371/journal.pone.0065276.g002
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